Read more about the article Struggling DNA testing firm 23andMe to be bought for $256m
Struggling DNA testing firm 23andMe to be bought for $256m

Struggling DNA testing firm 23andMe to be bought for $256m

Lily JamaliNorth America Technology Correspondent•@lilyjamaliReporting fromSan Francisco, CAReutersThe DNA testing firm 23andMe says it has entered into an agreement to be acquired by Regeneron Pharmaceuticals for $256m (£192m).It comes two…

Continue ReadingStruggling DNA testing firm 23andMe to be bought for $256m

End of content

No more pages to load